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Aberrant or chronic microglial activation is strongly implicated in neurodegeneration,
where prolonged induction of classical inflammatory pathways may lead to
a compromised blood-brain barrier (BBB) or vasculature, features of many
neurodegenerative disorders and implicated in the observed cognitive decline. BBB
disruption or vascular disease may expose the brain parenchyma to “foreign” plasma
proteins which subsequently impact on neuronal network integrity through neurotoxicity,
synaptic loss and the potentiation of microglial inflammation. Here we show that the
blood coagulation factor fibrinogen (FG), implicated in the pathogenesis of dementias
such as Alzheimer’s disease (AD), induces an inflammatory microglial phenotype as
identified through genetic microarray analysis of a microglial cell line, and proteome
cytokine profiling of primary microglia. We also identify a FG-mediated induction of non-
cell autonomous ER stress-associated neurotoxicity via a signaling pathway that can
be blocked by pharmacological inhibition of microglial TNFα transcription or neuronal
caspase-12 activity, supporting a disease relevant role for plasma components in
neuronal dysfunction.
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INTRODUCTION
Midlife elevated plasma levels of systemic inflammatory markers such as fibrinogen and
albumin are correlated with reduced brain volumes in brain areas associated with dementia
such as Alzheimer’s disease (AD) in later life (Walker et al., 2017). Blood brain barrier
(BBB) and cerebral vascular integrity can weaken in normal aging and in neurodegenerative
diseases, and may contribute to cognitive decline (Hainsworth et al., 2017; Sweeney
et al., 2018). Deposition of blood-borne proteins in the CNS parenchyma may occur in
neurodegenerative diseases such as AD (Lipinski and Sajdel-Sulkowska, 2006; Ryu and McLarnon,
2009; Miners et al., 2018) and depletion of blood-borne factors, specifically fibrinogen
(FG) are protective in animal models of neurodegeneration (Cortes-Canteli et al., 2012).
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Fibrinogen may enter the brain via small cerebral microbleeds
or microhaemorrhages (Werring et al., 2010), which are
associated with the development of depressive symptoms in AD
(Leeuwis et al., 2017), an often early event in AD (Cortés et al.,
2018), and the inflammatory activation of microglia (Ahn et al.,
2018). In line with this, infiltration of plasma proteins into
the CNS precipitates neurotoxic signaling cascades through the
activation of microglia (Huang et al., 2008; Hooper et al., 2009;
Ryu and McLarnon, 2009; Weinstein et al., 2009). Furthermore,
systemic inflammation is correlated with future cognitive decline
in AD (Holmes et al., 2009). Moreover FG can induce pro-
inflammatory cytokine secretion from peripheral blood cells
(Jensen et al., 2007). In addition, elevated plasma FG levels are a
risk factor for AD and vascular dementia, (van Oijen et al., 2005;
Xu et al., 2008), a proposed CFS biomarker for AD (Lee et al.,
2007) and the development of cognitive impairment after stroke
(Gillett et al., 2018).
Fibrinogen signals through an integrin class of receptor,
Mac-1 (or αMβ2, CD11b/CD18), expressed by microglia and
macrophages (Adams et al., 2007) which is upregulated in AD
brain (Akiyama and McGeer, 1990). This signaling stimulates
the secretion of pro-inflammatory cytokines and chemokines
(Smiley et al., 2001; Piers et al., 2011). Thus, it seems plausible
that FG-induced deficits in neuronal viability are due to aberrant
inflammatory signaling. Historically, investigations into chronic,
aberrant neuronal loss have focussed on classic apoptotic
pathways centered on mitochondrial signaling. However, an
endoplasmic reticulum (ER) centered hypothesis for the neuronal
death occurring in neurodegenerative diseases has also been
proposed (Lindholm et al., 2006). ER stress is a well-characterized
cellular phenomenon, whereby an accumulation of misfolded
proteins and calcium dys-homeostasis lead to disturbances
in the structure and function of the ER (Gerakis and Hetz,
2018). Under normal circumstances, highly conserved unfolded
protein response (UPR) adaptive mechanisms rebalance cellular
homeostasis. However, if the accumulation of misfolded proteins
is prolonged, as observed in AD models (Nakagawa et al.,
2000), apoptotic cell signaling cascades are induced, leading
to significant cytotoxicity (Nakagawa et al., 2000; Gerakis
and Hetz, 2018; Morris et al., 2018). Interestingly, increased
pro-inflammatory cytokine release, specifically tumor necrosis
factor-α (TNFα) and interleukin-6 (IL-6), can induce ER stress
signaling in fibroblast cell lines and in vivo (Xue et al.,
2005; Denis et al., 2010; O’Neill et al., 2013). Conversely,
ER stress can also mediate upregulation of pro-inflammatory
cytokines (Chen et al., 2013), suggesting the possibility of
a self-perpetuating mechanism of detrimental signaling in
neurodegenerative diseases centered on ER stress and aberrant,
or chronic, inflammatory signaling. With this in mind, we aimed
to identify if exposure to FG modulated inflammatory signaling
and subsequent neuronal toxicity in a well-characterized in vitro
neuronal cell culture model, which can be pharmacologically
manipulated to eliminate the presence of microglia (Piers et al.,
2011; Jebelli et al., 2015). Here, we identify for the first time, a
FG-induced increase in neurotoxicity via a non-cell autonomous
mechanism involving a microglial TNFα-mediated induction of
neuronal ER stress signaling.
MATERIALS AND METHODS
Materials
Fibrinogen, lipopolysaccharide from Escherichia coli (055:B5;
LPS), tunicamycin, thapsigargin, leucine-methyl-ester (LME),
staurosporine, hirudin, and Isolectin B4 from Griffonia
simplicifolia-FITC conjugated were from Sigma (Dorset,
United Kingdom) and thalidomide was from Tocris Bioscience
(Bristol, United Kingdom). Quantikine M TNFα. TGF-β and
IL-6 ELISA kits, z-VAD-FMK and z-ATAD-FMK were from
R&D Systems (Abingdon, United Kingdom). Caspase 12 (FITC-
ATAD-FMK) activity kits were from Promokine (Heidelberg,
Germany) and caspase 3/7 (FAM-DEVD-FMK) activity kits
were from Millipore (Watford, United Kingdom). Anti-ED1,
anti-CD11b and rat IgG isotype controls were from AbD Serotec
(Kidlington, United Kingdom), anti-caspase 12 and goat anti-
rat-FITC were from Abcam (Cambridge, United Kingdom).
Goat anti-rabbit IgG horseradish peroxidase (HRP) and goat
anti-mouse IgG HRP were from Autogen Bioclear (Calne,
United Kingdom).
Methods
BV2 Microglial Cell Line Culture
BV2 microglia were maintained in DMEM with 10% foetal
bovine serum (FBS), supplemented with 2 mM L-glutamine,
100 U/ml penicillin and 100 mg/ml streptomycin at 37◦C in a
humidified atmosphere with 5% CO2. Prior to experimentation,
BV2 microglia were harvested and plated in serum-free
DMEM.
Preparation of Enriched Neuronal-Glial Cultures
(ENGC)
Primary cultures of enriched neuronal-glial cerebellar cultures
were isolated from 3 to 6 day-old Sprague Dawley rat pups and
prepared as described previously (Piers et al., 2011) in accordance
with the United Kingdom Animals (Scientific Procedures) Act,
1986. Cells were plated on 13 mm poly-D-lysine (PDL) coated
glass coverslips at a density of 8 × 105 per coverslip and
maintained in ENGC medium (Neurobasal medium with 2%
B27 neuronal supplement, 20 mM KCl, 6 g/l D-Glucose, 2 mM
L-Glutamine, 50 U/ml penicillin, and 50 µg/ml streptomycin).
After 36 h in vitro, cytosine furanoarabinoside (10 µM) was
added to prevent proliferation of non-neuronal cells. The
cultures were maintained at 37◦C in 5% CO2 and used at 7
DIV.
Microglial Ablation From ENGCs
Microglia present in the ENGCs were depleted with 25 mM
leucine-methyl-ester (LME), as previously described (Jebelli et al.,
2015).
Preparation of Primary Cultured Microglia
Microglia were isolated from 5-day-old Sprague Dawley rat pups,
as previously described (Piers et al., 2011) in accordance with the
United Kingdom Animals (Scientific Procedures) Act, 1986. Cells
were plated at a density of 5 × 104/well on 13 mm coverslips or
1 × 106/well in 60 mm culture dishes. After 24 h in vitro, the
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medium was replaced with serum-free ENGC medium and the
cultures were left to rest for at least 3 h prior to stimulation.
Fibrinogen Preparation
Fibrinogen was prepared in ultrapure, endotoxin-free water at
1000 × final concentration and sonicated prior to addition to
cell cultures. The final concentrations used are in line with those
previously used in vitro (Schachtrup et al., 2010).
Microarray Analyses
Extracted RNA from control and FG-treated BV2 cultures
(miRNeasy; Qiagen) was sent to AROS Applied Biotechnology
(Denmark) for microarray analysis using a MouseRef-8 v2.0
Expression Array (Illumina). Experimental procedures (cDNA
labeling and hybridization) were performed according to
manufacturer’s instructions. Bead Arrays were scanned using
the Illumina Bead Station 500X, and raw intensity values were
saved in Illumina’s Bead Studio program manager. For array
hybridization, all samples were distributed among different
arrays to minimize batch effect. Analysis was performed
using Partek Genomics Suite 6.6 (Partek, Inc., St. Louis, MO,
United States) and Lumi R package (Bioconductor, Du et al.,
2008). Raw expression data were log2 transformed, and all
samples were quantile normalized. QC plots before and after
normalization were generated for data quality analysis. Individual
probes were excluded from analysis if the detection p-value was
>0.05 in more than 2 out of the 3 repeats for any condition.
Samples were also excluded if <95% of the probes were detected
(all samples met this quality control criterion). A conservative
statistical threshold of FDR <0.05 and minimum fold difference
≥1.5 between sample groups was used in all comparisons and to
generate gene lists.
Assessment of Cell Death
Live ENGCs were incubated with propidium iodide (PI; 5 µg/ml)
and Hoechst 33342 (5 µg/ml). Using Image J analysis software
(NIH, United States), dead cells (PI + ) were quantified as a
percentage of total cell number, the latter obtained by Hoechst
33342 staining. A minimum of 3 fields per coverslip were
counted, and at least 3 coverslips were assessed for each variable
per experiment in at least 3 separate experiments as previously
described (Piers et al., 2011).
Immunocytochemistry
Cultures were fixed in 4% paraformaldehyde (PFA) in phosphate
buffered saline (PBS) then permeabilised in 100% methanol. Cells
were blocked with PBS containing 4% normal goat serum and
then incubated with primary antibodies overnight at 4◦C (1:100
anti-ED1, 1:100 anti-CD11b, or anti-rat IgG isotype control).
After washing, cells were incubated with goat anti-rat FITC
(1:100) in PBS. For microglia identification, FITC conjugated
lectin (IB4) (Streit, 1990) was administered at the same time as
the secondary antibodies. Cultures were washed and incubated
with DAPI solution prior to mounting with Vectashield (Vector
Labs Inc, Burlingame, CA, United States).
Assessment of Caspase 12 or Caspase 3/7 Induction
ENGCs were assessed for the induction of caspase-12
and caspase-3/7 after treatment as per the manufacturer’s
instructions. After treatment, coverslips were removed
and mounted into a basic medium consisting of 153 mM
NaCl, 3.5 mM KCl, 0.4 mM KH2PO4, 20 mM N-Tris
(hydroxymethyl)methyl-2-aminoethanesulphonic acid (TES),
5 mM NaHCO3, 1.2 mM Na2SO4, 1.2 mM MgCl2, 1.3 mM CaCl2,
5 mM glucose, warmed to 37◦C and observed immediately using
fluorescence microscopy (Zeiss, Oberkochen, Germany).
Cultures were counterstained with Hoechst for total cell
number and PI for total cell death using automatic exposure
settings. A minimum of 3 fields per coverslip was counted,
and at least 4 coverslips were assessed for each treatment per
experiment. Manual exposure settings were optimized against a
positive control then fixed for entire experiments. Analysis was
performed using Image J software (NIH, United States).
Western Blotting
Soluble protein lysates were resolved by SDS-PAGE
electrophoresis and transferred to PVDF membranes using
standard techniques. The following antibodies were used:
anti-caspase 12 (Abcam; 1:1000), anti-β-actin (Sigma; 1:10,000).
Immunoreactive bands were imaged and optical densities were
quantified using ImageJ software (NIH, United States) and
normalized to β-actin protein levels.
ELISA Determination of TNFα, TGF-β1 and IL-6
Quantification of secreted inflammatory cytokines TNFα, IL-
6 and TGF-β1 in microglial and ENGC culture supernatants
was determined with Quantikine M Rat Immunoassay kits
according to the manufacturer’s instructions. Briefly, microglial-
conditioned medium or ENGC-conditioned medium (MGCM or
ENGC-CM, respectively) was centrifuged at 4500 × g for 1 min
to remove any floating cells and assayed essentially as previously
described (Taylor et al., 2005). Cytokine concentrations were
determined against a standard concentration curve.
Cytokine Arrays and Pro-inflammatory Cytokine
Panel
MGCM was collected as above for cytokine analysis, supernatants
pooled from 3 independent experiments and incubated with
Proteome ProfilerTM Rat Cytokine array membranes (R&D
systems Panel A) as per the manufacturer’s instructions. Data
were analyzed using the Protein Array Analyser Palette plugin
(ImageJ), and plotted, as a mean ± SEM after normalizing to
membrane reference positive controls and intracellular protein
concentrations.
Statistical Analysis
All Western blots and PCR analyses were carried out at
least three times and those shown are representative. All
experiments were performed from at least three separate cell
preparations with internal replicates of at least 3 per experiment.
Significant differences were estimated using Welch’s two-sided
t-test or Student’s un-paired t-test with levels of significance at
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∗∗∗p < 0.001, ∗∗p < 0.01, and ∗p < 0.05; p > 0.05 was not
significant.
RESULTS
FG Exposure Enhances Inflammatory
Gene Expression and Release of
Pro-inflammatory Cytokines
To extend previous findings that FG can induce an inflammatory
microglial phenotype, we performed, in parallel, genetic
microarray analysis of the well-characterized BV2 mouse
microglia cell line, and pro-inflammatory cytokine release from
primary rat microglia cultures and enriched neuronal glial
cultures (ENGCs). Microarray analysis of BV2 cultures after
6 h of FG exposure identified a significant over-representation,
amongst others, of immune system and inflammatory gene
upregulation, including tnf, which encodes TNFα (Figure 1A
and Table 1). These findings were supported by cytokine release
data from rat microglia cultures where primary microglia
exposed to FG or lipopolysaccharide (LPS; as a positive control)
for 24 h showed significant TNFα secretion (Figure 1B).
A number of cytokines and chemokines, many of which are
regarded as inflammatory (Owen et al., 2011), were secreted to
significance by FG (Figure 1B) including TNFα, MMP-2, IL-6,
CXCL2, and CCL2. Whilst many mirrored the release evoked
with LPS, Fibulin-3 was secreted by FG stimulation only, whereas
IL-1β or IL-1α secretion was observed after LPS treatment, but
was absent in FG-treated cultures indicating that FG stimulation
of microglia is nuanced compared with LPS stimulation.
In support of previously published data identifying microglial
CD11b as a putative receptor for FG (Adams et al., 2007),
pre-incubation of primary microglial cultures with a CD11b
blocking antibody significantly attenuated the FG-induced TNFα
release, but had no effect on LPS-induced secretion (Figure 1C).
Given the perceived importance of microglia in mediating
the inflammatory effects of FG, and the potential for this
inflammation to impact on neuronal integrity, we determined
if the microglia present in ENGCs responded in a similar way
to isolated primary microglia. The ability to specifically ablate
microglia from the ENGCs (Jebelli et al., 2015) allows us to
determine any particular dependencies on these cells. In accord
with the data for proteome analysis for release of cytokines from
primary cultured microglia, exposure of ENGCs to either FG
or LPS significantly enhanced the release of TNFα (Figure 1D)
and another pro-inflammatory cytokine, interleukin-6 (IL-6;
Figure 1E), in a manner similar to that observed in primary
microglia cultures. Critically, when microglia were ablated from
ENGCs, the LPS- or FG-induced TNFα release (Figure 1C) and
IL-6 release (Figure 1D) were significantly attenuated. Further
characterization of cytokine release in the ENGCs revealed that
transforming growth factor-β1 (TGF-β1) secretion, a cytokine
known to have opposing cellular effects to TNFα (Bitzer et al.,
2000), was not significantly modulated by either LPS or FG
exposure, irrespective of the presence of microglia (Figure 1E),
this is possibly due to the dominating expression of this cytokine
by the astrocyte population present in the ENGCs (De Groot
et al., 1999). Taken together, these data suggest that FG exposure
skews microglia toward a pro-inflammatory phenotype.
FG Induced a Reactive Microglial
Phenotype
Confirmation of a FG-mediated induction of a reactive
microglial phenotype, as previously indicated (Adams et al.,
2007; Piers et al., 2011) was performed by immunocytochemical
analysis of characterized activated microglial markers. Control,
unstimulated, primary microglial cultures expressed low levels of
the activated microglial marker ED-1 (Figure 2Ai), and > 95%
of cells stained positive for IB4 (Supplementary Figure S1),
suggesting highly purified cultures, in a down-regulated state. In
support of FG-mediated activation, ED1 protein expression was
significantly enhanced when compared with non-treated control
cultures (Figure 2Aii). Furthermore, FG treatment significantly
increased the surface expression of its putative receptor, CD11b
(Figures 2Bi,ii), induction of which has previously been
associated with a phagocytic microglial phenotype (Adams et al.,
2007). These findings provide further support for a shift in
microglial activation when the cells are exposed to FG, although
interestingly whilst LPS evoked inducible nitric oxide synthase
(iNOS) expression in the microglia, FG did not, suggesting a
further divergence in activation profiles (Figure 2Aiii).
FG-Mediated Neurotoxicity Is Dependent
on Secreted Microglial Factors
Whilst it is clear that FG exposure can induce a pro-
inflammatory microglial phenotype, it is unclear whether this
induced phenotype would have an effect on neuronal viability.
To study this, we exposed ENGCs to FG and performed live
cell staining with Hoescht/propidium iodide (PI) for total/dead
cell analysis, respectively. After 24 h of exposure to FG,
the number of PI-positive cells increased significantly when
compared with non-treated controls (Figures 3Ai,Aii), which
did not increase further after 48 h of exposure (Figure 3Aii).
The cleavage of fibrinogen to fibrin by thrombin is a well-
defined mechanism in the coagulation cascade (Binnie and Lord,
1993), and thrombin transcripts are present in these cultures
when exposed to FG for 48 h (Supplementary Figure S2).
Therefore, it was possible that the observed toxicity was due
to cleavage of soluble fibrinogen to insoluble fibrin deposits.
To clarify this, cultures were co-treated with FG and the
thrombin inhibitor hirudin for 24 h. The percentage of PI-
positive cells in the FG + hirudin-treated cultures was not
significantly different from cultures treated with FG alone
(Figure 3B) suggesting soluble FG rather than cleaved fibrin
is the cause of the observed reduced neuronal viability. Death
was not due to endotoxin contamination of FG since polymyxin
B (PMX) treatment to remove endotoxin did not ablate FG-
induced death but did ablate LPS induced death (Supplementary
Figure S3).
To further characterize the death-signaling pathways induced
in the ENGCs by FG exposure, live cell staining for the
apoptotic executioner caspase-3/7 was performed, using the
Frontiers in Cellular Neuroscience | www.frontiersin.org 4 November 2018 | Volume 12 | Article 404
fncel-12-00404 November 20, 2018 Time: 16:14 # 5
Piers et al. Fibrinogen, ER Stress, Microglia
FIGURE 1 | FG induces early upregulation of inflammatory related genes and release of inflammatory cytokines. (A) Gene microarray performed on the BV2
microglial cell line after Fibrinogen (2.5 mg/ml) exposure for 6 h compared with non-stimulated (Control) BV2 cells at 6 h. (B) Proteome array performed on primary
microglia following 24 h of stimulation with lipopolysaccharide (LPS, 1 µg/ml), Fibrinogen (FG, 2.5 mg/ml) or non-stimulated cells (Control). (C) TNFα secretion in cell
(Continued)
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FIGURE 1 | Continued
culture medium by ELISA following treatment of primary microglia for 24 h with LPS (1 µg/ml), FG (2.5 mg/ml) or non-stimulated (Ctrl) ± MAC-1 receptor blocking
antibody ( + CD11b, 10 µg/ml) or rat IgG as isotype control ( + IgG, 10 µg/ml). (D) ENGCs treated for 24 h with LPS (1 µg/ml), FG (0.1–2.5 mg/ml) or
non-stimulated (Ctrl), and where indicated, pre-treated with 25 mM leucine-methyl-ester ( + LME) for microglia ablation, followed by ELISA analysis of TNFα secretion
in culture medium. (E) ENGCs treated as (D) followed by ELISA analysis of IL-6 secretion in culture medium. (F) ENGCs treated as (D) followed by ELISA analysis of
TGFβ secretion in culture medium. In all graphs, data are the mean ± SEM from 3 independent experiments with internal replicates of at least 3. Significance levels
compared with control condition unless otherwise indicated, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
fluorescent substrate FAM-DEVD-FMK (Darzynkiewicz et al.,
2002). Following 24 h exposure to FG, a significant increase
in caspase-3/7 activity was observed, when compared with
non-treated control cultures (Figures 3Ci,Cii). Interestingly
the most pronounced staining seemed to correlate with cells
with large, rounded cytoplasmic morphology, uncharacteristic
of neuronal anatomy (white arrow heads, Figure 3Ci), and
unlike the prominent staining observed after staurosporine
(STS; positive control for the induction of apoptosis) exposure
(Figures 3Ci,Cii). These cells fit the description of microglia
that we know are present in the ENGCs as confirmed with
IB4 staining and previously published literature (Figure 3Ciii;
Piers et al., 2011; Jebelli et al., 2015). Furthermore, previous
studies have suggested that microglial activation is dependent
on non-apoptotic caspase-3 activity (Shen et al., 2017).
Therefore, we wanted to identify whether microglial caspase-3
activity was important in the observed reduction in neuronal
viability. Initially, we performed microglial ablation on ENGCs
and found that removal of microglia from the cultures
significantly attenuated the observed FG-mediated neuronal
death (Figure 3D). Interestingly, LPS mediated neuronal
death was not significantly different from control levels,
suggesting that whilst the ability of FG and LPS to modulate
microglial reactivity is similar in terms of cytokine release, the
underlying mechanisms of any subsequent neuronal insults differ
(Figure 3D).
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FIGURE 2 | FG induces microglial reactivity. (A) Control primary rat microglia (Ctrl) or microglia exposed to FG (2.5 mg/ml) or LPS (1 µg/ml) for 24 h followed by
immunocytochemistry for ED1 and iNOS (Scale bar: 30 µm; Ai), and nuclear co-staining with DAPI (blue), quantified as a % percentage of cells expressing ED1 (Aii),
or iNOS (Aiii). (B) Immunofluorescence of surface CD11b staining in primary microglial cultures following 24 h of FG treatment (Scale bar: 60 µm; Bi) and nuclear
co-staining with DAPI (blue), quantified as a % percentage of CD11b + cells, compared with control (Bii). Data represent the mean ± SEM of 5 defined fields from
at least three independent experiments. Significance levels are ∗∗∗p < 0.001, ∗∗p < 0.01 compared with relevant control.
Further support for the involvement of microglia in FG-
mediated neuronal death, specifically, the secreted factors
from microglia, was identified by exposing microglia-depleted
ENGCs to conditioned medium from primary microglia cultures
(MGCM) exposed to FG (Figure 3E). We observed a significant
increase in neuronal death when ENGCs were exposed to
MGCM from FG-treated microglial cultures when compared
to the addition of control MGCM, which could be attenuated
by boiling the MGCM prior to its addition to the ENGCs
(Figure 3E). Carry-over of FG in MGCM to exert a direct
effect is also unlikely since negligible FG was detected in FG-
MGCM (Supplementary Figure S4). Finally, we found it was
possible to attenuate the effect of MGCM from FG-treated
microglia cultures on ENGCs by pre-incubating the microglia
cultures with the caspase-3/7 inhibitor z-VAD-FMK (Figure 3F).
MG exposed to FG, or LPS, showed caspase-3 activation
but no pyknotic nuclei suggesting non-apoptotic activation of
caspase-3 (Supplementary Figure S6). Taken together, these
data strongly support a microglial-mediated mechanism for
the observed increase in FG-induced neurotoxicity, centered
on the release of soluble factors, and suggests a possible
role for non-apoptotic activation of caspase-3 in microglia
within this mechanism, as our previous investigations found
no significant increase in PI-positive (i.e., dead cells) nuclei
in primary microglial cultures exposed to FG (Piers et al.,
2011).
FG Induces ER Stress-Associated
Neuronal Death via Microglial TNFα
Release
Based on our microarray and cytokine release data, one
candidate for a soluble released factor from microglia that may
enhance neurotoxicity is TNFα. Studies suggest inflammatory
cytokines including TNFα can induce ER stress signaling
(Xue et al., 2005; Denis et al., 2010; O’Neill et al., 2013;
Dandekar et al., 2015). Cleavage of the ER-located caspase-12
during ER stress triggers downstream apoptotic pathways and
is implicated in neurodegenerative disease models associated
with BBB dysfunction (Nakagawa et al., 2000). Therefore, we
investigated a possible role for TNFα in an ER stress associated
mechanism of neurotoxicity. Initially, we found that exposure
of ENGCs to FG induced an increase in activated caspase-12
expression as measured by western blotting for the cleaved form
of the protein (Figures 4Ai,Aii,Aiii), to levels comparable with
the known ER stress inducers, thapsigargin (a specific inhibitor
of the sarco-ER calcium-ATPase, SERCA), or tunicamycin (a
blocker of protein glycosylation; Nair et al., 2007; Tu). In
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FIGURE 3 | FG-mediated neurotoxicity is dependent on secreted microglial factors. (A) Live cell staining with propidium iodide (PI) of ENGCs for analysis of cellular
death after FG treatment for 24–48 h (Scale bar: 15 µm; Ai), quantified as a percentage of PI + cells in the population (Aii). (B) Quantification of cell death in ENGCs
after treatment with 2.5 mg/ml FG for 24 h + /– hirudin (40 U/ml). (C) Analysis of caspase 3/7 activity by FAM-DEVD-FMK live cell staining in ENGCs following
exposure to FG (2.5 mg/ml) or staurosporine (STS, 0.5 µM; Scale bar: 20 µm) for 24 h, Ci. Data were quantified and presented as arbitrary fluorescence units
(AFU)/cell/field of view; Cii). Confirmation of the presence of microglia in ENGCs with IB4 cell staining (Ciii). All cellular populations were counterstained with Hoechst
33342 (blue). (D) Assessment of ENGC death by PI live cell staining after treatment with FG (2.5 mg/ml) or LPS (1 µg/ml) for 24 h before and after microglial ablation
( + LME). (E) Analysis of ENGC death by PI live cell staining after exposure to microglial conditioned medium (MGCM) collected from cultures treated for 24 h with FG
(0.1–2.5 mg/ml) or untreated (Ctrl). Some MGCM samples from FG treated cultures were boiled to inactivate prior to addition. (F) Analysis of ENGC death by PI live
cell staining after exposure to MGCM collected from cultures treated for 24 h with FG (2.5 mg/ml) + /– z-VAD-FMK, or untreated (Ctrl). In all graphs, data are the
mean ± SEM from at least three independent experiments with internal replicates of at least 3. Significance levels are compared with control condition in each graph
unless otherwise indicated, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
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FIGURE 4 | FG inducesneuronal ER stress signaling via microglial TNFα release. (A) Expression of pro-caspase 12 (55 kDa) and cleaved active caspase
12 (36 kDa) in ENGCs from control cultures (Ctrl), or cultures treated with FG (2.5 mg/ml), thapsigargin (Th, 2 µM), or tunicamycin (Tu, 1 µg/ml) for 24 h as shown in the
(Continued)
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FIGURE 4 | Continued
representative blot (Ai), and quantified by densitometry of cleaved caspase-12 relative to β-Actin levels (Aiii). Aii represents a blot showing time course of expression
of cleaved caspase-12 in ENGCs treated with FG (2.5 mg/ml) over time (h). (B) Analysis of caspase-12 activity by FITC-ATAD-FMK live cell staining in ENGCs
following exposure to FG + /− thalidomide (Thal; 40 µM) or z-VAD-FMK (z-VAD; 1 µg/ml), or thapsigargin (Th, 2 µM) for 24 h. (Bi), Scale bar: 20 µm. Data were
quantified and presented as arbitrary fluorescence units (AFU)/cell/field of view; Bii). (C) Analysis of death in ENGCs by PI live cell staining after exposure to microglial
conditioned medium (MGCM) collected from cultures treated FG (2.5 mg/ml) or untreated (Ctrl) + /− direct administration of the caspase-12 specific inhibitor
z-ATAD-FMK. Th, thapsigargin, 2 µM, Tu, Tunicamycin, 1 µg/ml Staurosporine (STS; 0.5 µM) was used as a positive control for neuronal death. (D) Western blot of
cleaved caspase-12 in ENGCs following expose to Thapsigargin (Th, 2 µM) or FG (2.5 mg/ml) in the presence of z-VAD-FMK (1µg/ml) showing inhibition of
caspase-12 cleavage (arrow). (E) Quantification of the relative active caspase-12 fluorescence intensity/cell in ENGC cultures after treatment with Th (2 µM), Tu
(1 µg/ml), FG (2.5 mg/ml), or LPS (1 µg/ml) for 24 h, + /− LME pre-treatment for the depletion of microglia (LME). Data are presented in arbitrary fluorescent units
(AFU)/cell/field of view). (F) ELISA of TNFα secretion from primary microglial cultures following treatment for 24 h with FG (2.5 mg/ml, or LPS (1 µg/ml), co-treated
with thalidomide (Thal; 10 µg/ml). In all graphs, data are the mean ± SEM from at least three independent experiments encompassing 5 separate fields of view or
from samples from at least three independent experiments. Significance levels are compared with control condition in each graph unless otherwise indicated,
∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
support of these findings, live cell staining experiments of ENGCs
after FG treatment identified significant increases in caspase-
12 activity, comparable with levels observed after thapsigargin
treatment (Figures 4Bi,Bii). Furthermore, inhibition of caspase-
3/7 with z-VAD-FMK, or specific inhibition of TNFα synthesis by
thalidomide treatment, was sufficient to attenuate the increased
levels of caspase-12 expression (Figures 4Bi,Bii), supporting
the hypothesis that a released factor involved in the induction
of neurotoxic ER stress signaling was TNFα. In confirmation
of ER stress activation, we found CHOP transcripts were also
significantly enhanced in microglia exposed to FG (2.5 mg/ml)
or LPS (1 µg/ml) for 24 h or Thapsigargin (2µM, as a positive
activator of ER stress) (Supplementary Figure S5).
In support of the critical induction of these signaling cascades
in the observed FG-mediated neurotoxicity, MGCM from
cultures exposed to FG were unable to induce significant
neuronal toxicity in ENGCs pre-treated with the caspase-
12 specific inhibitor z-ATAD-FMK (Figure 4C). Inhibition
of caspase-3/7 also reduced caspase-12 cleavage in ENGCs,
suggestive of an upstream mechanism involving microglial
activation (Figure 4D). Concomitantly, removal of microglia
from ENGCs prevent FG-mediated induction of caspase-12,
further supporting a non-cell autonomous mechanism (Figure
4E). Moreover, thalidomide significantly reduced TNFα
secretion from microglia treated with FG (Figure 4F). Together,
these findings suggest a signaling cascade initiated by FG-
mediated microglial activation leading to a non-cell autonomous
neurotoxicity via released TNFα and subsequent induction of
neuronal ER stress signaling.
DISCUSSION
After confirming an immune/inflammatory consequence in
microglia after exposure to FG, both through microarray
analysis of a microglial cell line and proteome analysis of
secreted cytokines in primary cultures, we identified a non-cell
autonomous signaling cascade capable of inducing neurotoxicity
through a mechanism that depended on microglial-released
TNFα and neuronal ER stress. Importantly we were able to
pharmacologically inhibit the FG-induced neurotoxicity either
by targeting TNFα transcription with the putative inhibitor,
thalidomide, or by blocking neuronal caspase-12 activity with
the specific inhibitory peptide z-ATAD-FMK. It cannot be
discounted that thalidomide may also block transcription of other
inflammatory mediators such as IL-6 or that other factors play a
role in death cascades induced by FG. For example we show also
that IL-6 is secreted by microglia in response to FG. However,
thalidomide has been shown to selectively inhibit TNFα
secretion from immune cells (Sampaio et al., 1991) strongly
suggesting TNFα plays a pivotal role in the inflammatory-linked
neurotoxicity observed here. Linkage between increased pro-
inflammatory cytokine release, particularly TNFα and IL-6, and
the induction of ER stress signaling is supported by others
(Xue et al., 2005; Denis et al., 2010; Lourenco et al., 2013;
O’Neill et al., 2013). Interestingly elevated systemic fibrinogen,
TNFα and IL-6 in mid-life have also been linked with brain
shrinkage, cognitive decline, and AD in later life (Marsland
et al., 2008; Holmes et al., 2009). Furthermore, ER stress can
mediate upregulation of pro-inflammatory cytokines (Chen et al.,
2013; Morris et al., 2018) and neuronal ER stress has been
linked to inflammation and AD pathology (Salminen et al.,
2009). Whilst in rodents, activation of caspase 12 leads to ER
stress, in humans, the gene may produce a truncated non-
functional protein; caspase 4 in humans is regarded as the
homolog for caspase 12 in rodents (Gao and Wells, 2013). Human
cell lines have been shown to respond to AD-linked amyloid
beta peptides, with ER stress induced caspase-4 activation
similarly to the activation of ER stress and subsequent caspase-
12 by AD-linked amyloid beta peptides in rodents (Nakagawa
et al., 2000). Thus future work on human microglia should
take into consideration the role of both caspase 4 (Hitomi
et al., 2004) and caspase 12 in fibrinogen-induced activation of
microglia.
Taken together our present findings are the first to directly
link FG induced release of TNFα to an induction of neuronal
ER stress. The current neurotoxicity results are unlikely to be due
to a direct FG crossover in the MGCM because blotting of the
conditioned medium for FG revealed extremely low levels of the
protein, below the effective concentration.
It is of course highly likely that other unidentified
factors contribute to the mechanism. Previously we
identified that TNFα-induced neuronal death cascades
required a cofactor (Taylor et al., 2005), and indeed,
Denis et al. (2010) found TNFα alone was unable to
induce a full ER stress response. Interestingly, however,
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TNF inhibitors have been recently proposed as a repurposed
therapy for dementias such as AD (Mason et al., 2018).
Furthermore, as mentioned above, IL-6 was also secreted in
response to FG and elevation of this cytokine has been implicated
in a number of neurodegenerative diseases including AD
(Rothaug et al., 2016). Increasing evidence links changes in brain
parenchymal and plasma levels of fibrinogen with microglial
and inflammatory responses in a number of neurodegenerative
diseases including multiple sclerosis (Adams et al., 2007; Ryu
and McLarnon, 2009; Acunˇa et al., 2017) and Alzheimer’s
disease (Cortes-Canteli et al., 2012) and following stroke (Luan
et al., 2017). Here we present new evidence of a pathway
activated in microglia by fibrinogen which has ramifications for
neuronal survival and which has not yet been observed in these
conditions.
CONCLUSION
Our findings suggest a FG-induced TNFα-non-cell autonomous
microglial-neuronal ER stress mediated pathway with
implications for early signaling cascades activated in
inflammatory-mediated dementias such as AD.
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